Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma

European Journal of Pharmacology

Volumn 667, Issue 1-3, 2011, Pages 136-143

  Sun, Cui Cui ^a   Zhang, Yu Sheng ^a   Xue, Xia ^a   Cheng, Yan Na ^a   Liu, Hui Ping ^a   Zhao, Cui Rong ^a   Lou, Hong Xiang ^a   Qu, Xian Jun ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Angiogenesis; Angiogenic factor; Macrocyclic bisbibenzyl; Mean vascular density; Riccardin D; Xenograft

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; MATRIX METALLOPROTEINASE; RICCARDIN D; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANGIOGENESIS INHIBITORS; ANIMALS; BLOOD VESSELS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LUNG NEOPLASMS; MACROCYCLIC COMPOUNDS; MICE; NEOVASCULARIZATION, PATHOLOGIC; PHENYL ETHERS; STILBENES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80052032183     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.06.013     Document Type: Article

References (41)

1. L. Albitar, G. Pickett, M. Morgan, J.A. Wilken, N.J. Maihle, and K.K. Leslie EGFR isoforms and gene regulation in human endometrial cancer cells Mol. Cancer 9 2010 166
2. D. Bausch, T. Pausch, T. Krauss, U.T. Hopt, C. Fernandez-Del-Castillo, A.L. Warshaw, S.P. Thayer, and T. Keck Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma Angiogenesis 2011 10.1007/s10456-011-9207-3
3. A. Bhaskar, J. Bala, A. Varshney, and P. Yadava Expression of measles virus nucleoprotein induces apoptosis and modulates diverse functional proteins in cultured mammalian cells PLoS One. 6 2011 e18765
4. P.C. Black, and C.P. Dinney Bladder cancer angiogenesis and metastasis-translation from murine model to clinical trial Cancer Metastasis Rev. 26 2007 623 634 (Pubitemid 350115114)
5. G. Bringmann, J. Mühlbacher, M. Reichert, M. Dreyer, J. Kolz, and A. Speicher Stereochemistry of isoplagiochin C, a macrocyclic bisbibenzyl from liverworts J. Am. Chem. Soc. 126 2004 9283 9290 (Pubitemid 38989446)
6. B. Canu, A. Fioravanti, P. Orlandi, T. Di Desidero, G. Alì, G. Fontanini, A. Di Paolo, M. Del Tacca, R. Danesi, and G. Bocci Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo Neoplasia 13 2011 217 229
7. M.H. Chen, S.X. Cui, Y.N. Cheng, L.R. Sun, Q.B. Li, W.F. Xu, S.G. Ward, W. Tang, and X.J. Qu Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity Anticancer Drugs 19 2008 957 965
8. J.S. Chen, Q. Wang, X.H. Fu, X.H. Huang, X.L. Chen, L.Q. Cao, L.Z. Chen, H.X. Tan, W. Li, J. Bi, and L.J. Zhang Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: association with MMP-9 Hepatol Res. 39 2009 177 186
9. A. Cheng, L. Sun, X. Wu, and H. Lou The inhibitory effect of a macrocyclic bisbibenzyl riccardin D on the biofilms of Candida albicans Biol. Pharm. Bull. 32 2009 1417 1421
10. S. Chouaib, C. Kieda, H. Benlalam, M.Z. Noman, F. Mami-Chouaib, and C. Rüegg Endothelial cells as key determinants of the tumor microenvironment: interaction with tumor cells, extracellular matrix and immune killer cells Crit. Rev. Immunol. 30 2010 529 545
11. N. Clere, S. Faure, J.J. Helesbeux, O. Duval, and R. Andriantsitohaina Paradoxical effects of ethoxidine, a topoisomerase I inhibitor, in the cellular processes leading to angiogenesis on endothelial cells Carcinogenesis 2011 10.1093/carcin/bgq260
12. K.J. Dedes, R. Natrajan, M.B. Lambros, F.C. Geyer, M.A. Lopez-Garcia, K. Savage, R.L. Jones, and J.S. Reis-Filho Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer Eur. J. Cancer 47 2011 138 150
13. A. De-Luca, M. Gallo, D. Aldinucci, D. Ribatti, L. Lamura, A. D'Alessio, R. De-Filippi, A. Pinto, and N. Normanno Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells J. Cell Physiol. 226 2011 2131 2138
14. J.L. Diaz-Rubio, A. Duarte-Rojo, M. Saqui-Salces, A. Gamboa-Dominguez, and G. Robles-Diaz Cellular proliferative fraction measured with topoisomerase IIalpha predicts malignancy in endocrine pancreatic tumors Arch. Pathol. Lab. Med. 128 2004 426 429 (Pubitemid 38451130)
15. I.J. Duignan, E. Corcoran, A. Pennello, M.J. Plym, M. Amatulli, N. Claros, M. Iacolina, H. Youssoufian, L. Witte, S. Samakoglu, J. Schwartz, D. Surguladze, and J.R. Tonra Pleiotropic stromal effects of vascular endothelial growth factor receptor 2 antibody therapy in renal cell carcinoma models Neoplasia 2011 49 59
16. F.J. Gao, S.X. Cui, M.H. Chen, Y.N. Cheng, L.R. Sun, S.G. Ward, N. Kokudo, W. Tang, and X.J. Qu Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells Life Sci. 83 2008 815 820
17. X. Li, B. Sun, C.J. Zhu, H.Q. Yuan, Y.Q. Shi, J. Gao, S.J. Li, and H.X. Lou Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells Toxicol. In Vitro 23 2009 29 36
18. Z.Q. Lu, P.H. Fan, M. Ji, and H.X. Lou Terpenoids and bisbibenzyls from Chinese liverworts Conocephalum conicum and Dumortiera hirsute J. Asian Nat. Prod. Res. 8 2006 187 192 (Pubitemid 43879883)
19. J.M. Melero-Martin, and A.C. Dudley Vascular stem cells and tumor angiogenesis Stem. Cells 2011 10.1002/stem.583
20. G.N. Naumov, M.B. Nilsson, T. Cascone, A. Briggs, O. Straume, L.A. Akslen, E. Lifshits, L.A. Byers, L. Xu, H.K. Wu, P. Jänne, S. Kobayashi, B. Halmos, D. Tenen, X.M. Tang, J. Engelman, B. Yeap, J. Folkman, B.E. Johnson, and J.V. Heymach Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance Clin. Cancer Res. 15 2009 3484 3494
21. R. Prudent, V. Moucadel, C.H. Nguyen, C. Barette, F. Schmidt, J.C. Florent, L. Lafanechère, C.F. Sautel, E. Duchemin-Pelletier, E. Spreux, O. Filhol, J.B. Reiser, and C. Cochet Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2 Cancer Res. 70 2010 9865 9874
22. F.H. Qi, A.Y. Li, H. Lv, L. Zhao, J.J. Li, B. Gao, and W. Tang Apoptosis-inducing effect of cinobufacini, Bufo bufo gargarizans Cantor skin extract, on human hepatoma cell line BEL-7402 Drug Discov. Ther. 2 2008 339 343
23. J. Rössler, Y. Monnet, F. Farace, P. Opolon, E. Daudigeos-Dubus, A. Bourredjem, G. Vassal, and B. Geoerger The selective VEGFR1-3 inhibitor axitinib (AG-013736) shows antitumor activity in human neuroblastoma xenografts Int. J. Cancer 2010 10.1002/ijc.25611
24. P. Saharinen, L. Eklund, K. Pulkki, P. Bono, and K. Alitalo VEGF and angiopoietin signaling in tumor angiogenesis and metastasis Trends Mol. Med. 2011 10.1016/j.molmed.2011.01.015
25. A.M. Schor, and S.L. Schor Angiogenesis and tumour progression: migration-stimulating factor as a novel target for clinical intervention Eye (Lond) 24 2010 450 458
26. J. Shen, G. Li, Q. Liu, Q. He, J. Gu, Y. Shi, and H. Lou Marchantin C: a potential anti-invasion agent in glioma cells Cancer Biol Ther. 9 2010 33 39
27. Y.Q. Shi, Y.X. Liao, X.J. Qu, H.Q. Yuan, S. Li, J.B. Qu, and H.X. Lou Marchantin C, a macrocyclic bisbibenzyl, induces apoptosis of human glioma A172 cells Cancer Lett. 262 2008 173 182
28. Y.Q. Shi, X.J. Qu, Y.X. Liao, C.F. Xie, Y.N. Cheng, S. Li, and H.X. Lou Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells Eur. J. Pharmacol. 584 2008 66 71
29. Y.Q. Shi, C.J. Zhu, H.Q. Yuan, B.Q. Li, J. Gao, X.J. Qu, B. Sun, Y.N. Cheng, S. Li, X. Li, and H.X. Lou Marchantin C, a novel microtubule inhibitor from liverwort with anti-tumor activity both in vivo and in vitro Cancer Lett. 276 2009 160 170
30. D.V. Skarlos, M. Bai, A. Goussia, E. Samantas, E. Galani, D. Tsavdaridis, M. Karina, P. Papakostas, A. Konstantara, and G. Fountzilas Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the hellenic cooperative oncology group Anticancer Res. 27 2007 2973 2983 (Pubitemid 47228031)
31. D.G. Teoh, and A.A. Secord Antiangiogenic therapies in epithelial ovarian cancer Cancer Control 18 2011 31 43
32. G. Tsakonas, and C. Kosmas Integration of novel targeted therapies into the systemic treatment of breast cancer-a review J BUON. 12 2007 319 327 (Pubitemid 47559298)
33. J.B. Wang, L.L. Qi, S.D. Zheng, H.Z. Wang, and T.X. Wu Curcumin suppresses PPARδ expression and related genes in HT-29 cells World J. Gastroenterol. 15 2009 1346 1352
34. S.B. Wang, Y.N. Cheng, S.X. Cui, J.L. Zhong, S.G. Ward, L.R. Sun, M.H. Chen, N. Kokudo, W. Tang, and X.J. Qu Des-gamma-carboxy prothrombin stimulates human vascular endothelial cell growth and migration Clin. Exp. Metastasis 26 2009 469 477
35. G.M. Xi, B. Sun, H.H. Jiang, F. Kong, H.Q. Yuan, and H.X. Lou Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity Bioorg. Med. Chem. 18 2010 6725 6733
36. D. Xiao, and S.V. Singh Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo Cancer Res. 67 2007 2239 2246 (Pubitemid 46424243)
37. R. Xiong, W. Lu, J. Li, P. Wang, R. Xu, and T. Chen Preparation and characterization of intravenously injectable nimodipine nanosuspension Int. J. Pharm. 350 2008 338 343
38. X. Xue, X.J. Qu, Z.H. Gao, C.C. Sun, H.P. Liu, C.R. Zhao, Y.N. Cheng, and H.X. Lou Riccardin D, a novel macrocyclic bisbibenzyl, induces apoptosis of human leukemia cells by targeting DNA topoisomerase II Invest. New Drugs 2010 10.1007/s10637-010-9554-8
39. X. Zhang, J.L. Zhong, W. Liu, Z. Gao, X. Xue, P. Yue, L. Wang, C. Zhao, W. Xu, and X. Qu N(3)-o-toluyl-fluorouracil inhibits human hepatocellular carcinoma cell growth via sustained release of 5-FU Cancer Chemother. Pharmacol. 66 2010 11 19
40. D. Zheng, Y. Wang, D. Zhang, Z. Liu, C. Duan, L. Jia, F. Wang, Y. Liu, G. Liu, L. Hao, and Q. Zhang In vitro antitumor activity of silybin nanosuspension in PC-3 cells Cancer Lett. 2011 10.1016/j.canlet.2011.03.028
41. A.X. Zhu, and E. Raymond Early development of sunitinib in hepatocellular carcinoma Expert Rev. Anticancer Ther. 9 2009 143 150